Funding Opportunities
CTP's Scientific Conference Grant Program Priorities
FDA recognizes the value of supporting high quality, small scientific conferences. A small scientific conference is defined as a symposium, seminar, workshop, or any formal meeting, whether conducted face-to-face or virtually to exchange information and explore a defined subject, issue, or area of concern impacting the public's health within the scope of the FDA's mission.
Current Funding Opportunities
-
Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01 - RFA-OD-22-023 or RFA-OD-22-024)
The purpose of this Funding Opportunity Announcement (FOA) is to provide support and protected time for an intensive, supervised career development experience in biomedical, behavioral, and social science research that will inform the development and evaluation of regulations on tobacco product manufacturing, distribution, and marketing and that will lead to research independence. Research projects must address the research priorities related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP).
Application due dates: February 21, 2023, November 14, 2023, July 12, 2024, March 12, 2025 by 5:00 PM local time of application organization. -
Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - RFA-OD-22-025 or RFA-OD-22-026)
The purpose of this FOA is to increase and maintain a strong cohort of new and talented independent investigators conducting research that will inform the development and evaluation of regulations on tobacco product manufacturing, distribution, and marketing. This program is designed to facilitate a timely transition of outstanding postdoctoral researchers with a research and/or clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions. This program will provide independent NIH research support during this transition in order to help awardees launch competitive, independent research careers. Research projects must address the research priorities related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP).
Application due dates: February 21, 2023, November 14, 2023, July 12, 2024, March 12, 2025 by 5:00 PM local time of application organization.
-
FY23 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science (FDABAA-23-00123)
FDA solicits and funds extramural research through an agency-wide Broad Agency Announcement (BAA) for advanced research and development proposals to support regulatory science and innovation. CTP participates in the BAA solicitation, and tobacco priority topics are included in sections I (A.3, C.12, D.9, F.10 & G.2) and III (D.3). More on these topics and application details can be found in the contract solicitation.
Stage One Submittal Packages due date: January 23, 2023.
- Maximizing the Scientific Value of Existing Biospecimen Collections: Scientific Opportunities for Exploratory Research (R21 Clinical Trial Not Allowed) (RFA-OD-21-004)
This Funding Opportunity Announcement (FOA) invites R21 applications to stimulate exploratory research relevant to the mission of the FDA Center for Tobacco Products (CTP) using existing (publicly available) biospecimens currently stored in repositories in the United States. This will include, but not be limited to, collections associated with the Population Assessment of Tobacco and Health (PATH) Study, the National Health and Nutrition Examination Survey (NHANES), the National Heart, Lung and Blood Institute’s (NHLBI) Biologic Specimen and Data Repository Information Coordinating Center (BioLINCC), and the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Proposed research should seek to maximize the scientific value of these stored collections and to provide researchers with an opportunity to generate preliminary data for subsequent research proposals. While other publicly available repositories would be considered, depending on analyses to be conducted, nationally representative analyses will receive priority. These applications need to provide justification why the data set is unique, and the research questions cannot be answered from a publicly available, nationally representative, data set.
Application due dates: October 8, 2021, August 8, 2022, March 8, 2023 by 5:00 PM local time of applicant organization.
Notice of Information for RFA-OD-21-004, "Maximizing the Scientific Value of Existing Biospecimen Collections (R21 Clinical Trial Not Allowed)" (NOT-OD-23-079)
The purpose of this Notice is to alert applicants to the final application date for RFA-OD-21-004, “Maximizing the Scientific Value of Existing Biospecimen Collections (R21 Clinical Trial Not Allowed)." The last application date for this RFA is March 8, 2023. There are no plans at this time to reissue this RFA.
- Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed) (RFA-OD-003)
This Funding Opportunity Announcement (FOA) invites R21 applications proposing the innovative analysis of existing (publicly available) nationally representative U.S. cross-sectional and longitudinal data, to investigate novel scientific ideas and/or to generate new models, systems, tools, methods, or technologies that have the potential for significant impact on biomedical or biobehavioral research in areas relevant to the FDA Center for Tobacco Products (CTP). Other publicly available data sets would be considered depending on the analyses to be conducted; however, nationally representative analyses will receive priority. Applications not using nationally representative data sets will need to provide justification why the data set is unique, and why the research questions cannot be answered from a (publicly available) nationally representative data set. This FOA encourages the analyses of public use datasets that may inform tobacco regulatory actions in the United States.
Application due dates: October 8, 2021, August 8, 2022, March 8, 2023 by 5:00 PM local time of applicant organization.
The purpose of this Notice is to alert applicants to the final application date for RFA-OD-21-003, “Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed)." The last application date for this RFA is March 8, 2023. There are no plans at this time to reissue this RFA.
- Tobacco Regulatory Science (R01 Clinical Trial Optional) (RFA-OD-21-002)
The purpose of this Funding Opportunity Announcement (FOA) is to invite R01 applications to support biomedical and behavioral research that will provide scientific data to inform regulation of tobacco products to protect public health. Research Projects must address the research priorities related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP). The awards under this FOA will be administered by NIH using funds that have been made available through FDA CTP and the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31). Research results from this FOA are expected to generate findings and data that are directly relevant in informing the FDA's regulation of the manufacture, distribution, and marketing of tobacco products to protect public health.
Application due date: July 14, 2021, February 15, 2022, July 14, 2022, and February 14, 2023 by 5:00 p.m. local time of applicant organization.
- FDA Support for Conferences and Scientific Meetings (R13)
FDA recognizes the value of supporting high quality, small scientific conferences. A small scientific conference is defined as a symposium, seminar, workshop, or any formal meeting, whether conducted face-to-face or virtually to exchange information and explore a defined subject, issue, or area of concern that impact the public's health within the scope of the FDA's mission.
Application due dates: April 12, 2021; October 12, 2021; April 12, 2022; and October 11, 2022 by 11:59 p.m. EST.
In addition to supporting research through NIH's programs, CTP solicits proposals for research contracts administered by FDA. Those opportunities are published through the Federal Business Opportunities website and also posted on the CTP website.